These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 24957223

  • 1. Changes in breast cancer risk distribution among Vermont women using screening mammography.
    Bolton KC, Mace JL, Vacek PM, Herschorn SD, James TA, Tice JA, Kerlikowske K, Geller BM, Weaver DL, Sprague BL.
    J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 24957223
    [Abstract] [Full Text] [Related]

  • 2. Registry-based study of trends in breast cancer screening mammography before and after the 2009 U.S. Preventive Services Task Force recommendations.
    Sprague BL, Bolton KC, Mace JL, Herschorn SD, James TA, Vacek PM, Weaver DL, Geller BM.
    Radiology; 2014 Feb; 270(2):354-61. PubMed ID: 24072778
    [Abstract] [Full Text] [Related]

  • 3. Comparing screening mammography for early breast cancer detection in Vermont and Norway.
    Hofvind S, Vacek PM, Skelly J, Weaver DL, Geller BM.
    J Natl Cancer Inst; 2008 Aug 06; 100(15):1082-91. PubMed ID: 18664650
    [Abstract] [Full Text] [Related]

  • 4. Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.
    Houssami N, Bernardi D, Caumo F, Brunelli S, Fantò C, Valentini M, Romanucci G, Gentilini MA, Zorzi M, Macaskill P.
    Breast; 2018 Apr 06; 38():150-153. PubMed ID: 29328943
    [Abstract] [Full Text] [Related]

  • 5. A prospective study of the use and effects of screening mammography in women aged 70 and older.
    Vacek PM, Skelly JM.
    J Am Geriatr Soc; 2015 Jan 06; 63(1):1-7. PubMed ID: 25537022
    [Abstract] [Full Text] [Related]

  • 6. Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.
    Wu WY, Törnberg S, Elfström KM, Liu X, Nyström L, Jonsson H.
    Breast Cancer Res; 2018 Dec 17; 20(1):153. PubMed ID: 30558679
    [Abstract] [Full Text] [Related]

  • 7. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
    Schousboe JT, Kerlikowske K, Loh A, Cummings SR.
    Ann Intern Med; 2011 Jul 05; 155(1):10-20. PubMed ID: 21727289
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Detection Rates for Benign and Malignant Diagnoses on Breast Cancer Screening With Digital Breast Tomosynthesis in a Statewide Mammography Registry Study.
    Fujii MH, Herschorn SD, Sowden M, Hotaling EL, Vacek PM, Weaver DL, Sprague BL.
    AJR Am J Roentgenol; 2019 Mar 05; 212(3):706-711. PubMed ID: 30673339
    [Abstract] [Full Text] [Related]

  • 10. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.
    Lee JM, Arao RF, Sprague BL, Kerlikowske K, Lehman CD, Smith RA, Henderson LM, Rauscher GH, Miglioretti DL.
    JAMA Intern Med; 2019 May 01; 179(5):658-667. PubMed ID: 30882843
    [Abstract] [Full Text] [Related]

  • 11. Performance of screening mammography among women with and without a first-degree relative with breast cancer.
    Kerlikowske K, Carney PA, Geller B, Mandelson MT, Taplin SH, Malvin K, Ernster V, Urban N, Cutter G, Rosenberg R, Ballard-Barbash R.
    Ann Intern Med; 2000 Dec 05; 133(11):855-63. PubMed ID: 11103055
    [Abstract] [Full Text] [Related]

  • 12. Breast cancer mortality trends in England and the assessment of the effectiveness of mammography screening: population-based study.
    Mukhtar TK, Yeates DR, Goldacre MJ.
    J R Soc Med; 2013 Jun 05; 106(6):234-42. PubMed ID: 23761583
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening.
    McDonald ES, Oustimov A, Weinstein SP, Synnestvedt MB, Schnall M, Conant EF.
    JAMA Oncol; 2016 Jun 01; 2(6):737-43. PubMed ID: 26893205
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Breast Cancer Incidence by Stage Before and After Change in Screening Guidelines.
    Guo F, Kuo YF, Berenson AB.
    Am J Prev Med; 2019 Jan 01; 56(1):100-108. PubMed ID: 30573138
    [Abstract] [Full Text] [Related]

  • 17. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
    Vreemann S, van Zelst JCM, Schlooz-Vries M, Bult P, Hoogerbrugge N, Karssemeijer N, Gubern-Mérida A, Mann RM.
    Breast Cancer Res; 2018 Aug 03; 20(1):84. PubMed ID: 30075794
    [Abstract] [Full Text] [Related]

  • 18. [Tailored Breast Screening Trial (TBST)].
    Paci E, Mantellini P, Giorgi Rossi P, Falini P, Puliti D, TBST Working Group.
    Epidemiol Prev; 2013 Aug 03; 37(4-5):317-27. PubMed ID: 24293498
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
    Kuhl CK, Strobel K, Bieling H, Leutner C, Schild HH, Schrading S.
    Radiology; 2017 May 03; 283(2):361-370. PubMed ID: 28221097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.